Evidence map›Paper›PMID 24012440›Full record

ArticleImmunobiology2014

Generation of a novel Cr2 gene allele by homologous recombination that abrogates production of Cr2 but is sufficient for expression of Cr1.

Luke R Donius, Christopher M Orlando, Janis J Weis, John H Weis

Open access · greenAbstract read
In one paragraph

Article in Immunobiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Luke R DoniusDivision of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, United States.
Christopher M Orlando
Janis J Weis
John H Weis
University of Utah · US

Funding

BORRELIA BURGDORFERI MITOGEN IN DEVELOPMENT OF ARTHRITISR01AI032223 · NIAID · UNIVERSITY OF UTAH · PI WEIS, JANIS J. · 1993 to 2023
$7.8M
Training Program in Microbial PathogenesisT32AI055434 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A, PLANELLES, VICENTE · 2004 to 2025
$6.0M
REGULATION OF CR2/CD21 EXPRESSION AND ACTIVATIONR01AI024158 · NIAID · UNIVERSITY OF UTAH · PI WEIS, JOHN · 1987 to 2012
$3.5M
Salmonella Antimicrobial Peptide ResistanceR01AI043521 · NIAID · OHIO STATE UNIVERSITY · PI GUNN, JOHN S · 2004 to 2013
$3.1M
SALMONELLA ANTIMICROBIAL PEPTIDE RESISTANCER29AI043521 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI GUNN, JOHN S · 1998 to 2002
$409k
Borrelia Burgdorferi Mitogen in Development of ArthritisR56AI032223 · NIAID · UNIVERSITY OF UTAH · PI WEIS, JANIS J. · 2013 to 2013
$350k
NIAID NIH HHS 5T32-AI-055434NIAID NIH HHS AI-24158NIAID NIH HHS AI-32223NIAID NIH HHS AI-43521NIAID NIH HHS R01 AI024158NIAID NIH HHS R01 AI032223NIAID NIH HHS R01 AI043521NIAID NIH HHS R29 AI043521NIAID NIH HHS R56 AI032223NIAID NIH HHS T32 AI055434
6 · The paper itself

Abstract

The enhancing effects of the complement system for humoral immunity have primarily focused upon the recognition of complement-bound foreign antigens by a co-receptor complex of the antigen-specific B cell receptor (BCR) and complement receptor 2 (Cr2). In vivo experiments using Cr2 gene deficient mice (which lack the expression of both the Cr1 and Cr2 proteins) do demonstrate depressed humoral responses to immunization but cannot be used to define specific contributions of the singular Cr1 or Cr2 proteins on B cell functions. To study the effect of a Cr2 deficiency in a Cr1 sufficient environment we created a mouse line in which the alternative splice site required for the expression of the Cr2 isoform was removed. This mouse line, Cr2KO, still expressed Cr1 on B cells but was deficient for the full length Cr2 protein. Surprisingly a new alternative splice within the Cr2 gene created a truncated product that encoded a novel protein termed iCr2 that was expressed on the surface of the cells. The Cr2KO mouse thus provides a new model system for the analysis of Cr1 and Cr2 functions in the immune response of the mouse.

Indexed as

AllelesAlternative SplicingAnimalsBlotting, WesternB-LymphocytesCell MembraneDendritic CellsFlow CytometryGene ExpressionHomologous RecombinationImmunohistochemistryMiceMice, KnockoutProtein IsoformsReceptors, Complement 3bReceptors, Complement 3dProtein IsoformsReceptors, Complement 3bReceptors, Complement 3dAlternative splicingB cell receptorB cellsBCRC3Complementcomplement component 3complement receptor 1complement receptor 2Complement receptorsCr1/CR1Cr2/CR2follicular dendritic cellFollicular dendritic cellsgeometric mean fluorescent intensitygMFIICiCr2incomplete Cr2isotype controlPCRpolymerase chain reactionsSCRshort consensus repeatsignal sequenceSSthymidine kinaseTKwild typeWT

Identifiers

PMID24012440
PMCPMC4133946
OpenAlexW2055608280

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.